title: Quantitative measurement of heparin in comparison with conventional anticoagulation monitoring and the risk of thrombotic events in adults on extracorporeal membrane oxygenation.
authors.affiliation: Department of Medicine, Boston University Medical Center, Boston, MA, USA.
authors.forename: David C
authors.initials: DC
authors.lastname: Chu
authors.forename: Abdel Ghanie
authors.initials: AG
authors.lastname: Abu-Samra
authors.forename: Grayson L
authors.initials: GL
authors.lastname: Baird
authors.forename: Cynthia
authors.initials: C
authors.lastname: Devers
authors.forename: Joseph
authors.initials: J
authors.lastname: Sweeney
authors.forename: Mitchell M
authors.initials: MM
authors.lastname: Levy
authors.forename: Christopher S
authors.initials: CS
authors.lastname: Muratore
authors.forename: Corey E
authors.initials: CE
authors.lastname: Ventetuolo
mesh_terms: D000328:Adult; D000925:Anticoagulants / Q000009:adverse effects / Q000627:therapeutic use*; D001777:Blood Coagulation / Q000187:drug effects* / Q000502:physiology; D001780:Blood Coagulation Tests; D016903:Drug Monitoring / Q000379:methods*; D015199:Extracorporeal Membrane Oxygenation / Q000009:adverse effects*; D006493:Heparin / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D012306:Risk; D013927:Thrombosis / Q000209:etiology*
chemical_list: D000925:Anticoagulants; D006493:Heparin